FDA Funding Bill In Senate Gives Generic Drugs More, But Commissioner Less
Executive Summary
A Senate Appropriations Committee-approved funding package would provide the Center for Drug Evaluation and Research with $5 million more than requested by the Obama administration
You may also be interested in...
Biosimilar, Generic and Rx User Fees Rely On Different Adjusters For Needed Appropriations
The biosimilar and generic drug user fees use different CPI measures, meaning they could increase the appropriations needed to allow user fee collection at different rates.
FDA's Medical Countermeasure Program Among Senate Funding Priorities
FDA should spend $19 million of an increase in non-user fee funding in fiscal 2012 on the agency’s medical countermeasures effort, the Senate Appropriations Committee recommends in the report that accompanies the Agriculture/FDA appropriations bill approved by the panel Sept 8.
FDA's Medical Countermeasure Program Among Senate Funding Priorities
FDA should spend $19 million of an increase in non-user fee funding in fiscal 2012 on the agency’s medical countermeasures effort, the Senate Appropriations Committee recommends in the report that accompanies the Agriculture/FDA appropriations bill approved by the panel Sept 8.